Misleading Glycated Hemoglobin Results in a Patient with Hemoglobin SC Disease
Author(s) -
Yihong Wang,
Bruce Beckwith,
Christopher Smith,
Gary L. Horowitz
Publication year - 2007
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2006.082917
Subject(s) - glycated hemoglobin , hemoglobin , hemoglobin s , medicine , disease , diabetes mellitus , endocrinology , type 2 diabetes , sickle cell anemia
We encountered a 62-year-old man with hemoglobin (Hb) SC disease. Diabetes mellitus had been previously diagnosed in this patient on the basis of 2 increased fasting glucose values. During an 8-year period, his glycated Hb (GHb) was measured by 3 different methods (Table 1⇓ ), each of which was affected differently by his Hb variants. The GHb results depended more on the method used than on the patient’s mean blood glucose.View this table: Table 1. HbA1c and related measurements over time.The patient’s GHb was measured initially (April 1997) by use of the Roche Hitachi Tina-quant immunoassay. In 2003–2004, we used the Tosoh 2.2 Plus, an assay based on HPLC, which produced chromatograms that were flagged as invalid, so we sent the patient’s samples to a commercial laboratory, which used the Roche Integra …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom